SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

Heron Therapeutics Q3 EPS $(0.42) Up From $(0.49) YoY, Sales $42.6M Up From $19.786M YoY

Heron Therapeutics (NASDAQ:HRTX) reported quarterly losses of $(0.42) per share. This is a 14.29 percent increase over losses of $(0.49) per share from the same period last year. The company reported $42.6 million in

Benzinga · -

Heron Therapeutics (NASDAQ:HRTX) reported quarterly losses of $(0.42) per share. This is a 14.29 percent increase over losses of $(0.49) per share from the same period last year. The company reported $42.6 million in sales this quarter. This is a 115.30 percent increase over sales of $19.786 million the same period last year.